PUBLISHER: Mordor Intelligence | PRODUCT CODE: 921248
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 921248
The market for surgical dressings is majorly driven by the rising number of surgeries across the globe and expected to grow with a CAGR of 5.2% over the forecasted period. The innovations in technology and the rising preference of the general population for minimally invasive surgeries are contributing to the growing volume of surgical procedures across the globe.
Another major driving factor for this market is the increasing number of cardiovascular disease-related surgeries, which in turn may increase the number of surgical procedures, which further may increase the demand for these products. Additionally, the number of bariatric surgical procedures conducted due to the increasing disease prevalence of diabetes and obesity is also estimated to grow, which may act as a driver for this industry. Therefore, the anticipated growth of the market can be attributed to an increase in diabetes based surgeries.
Moreover, the rising elderly population is also expected to drive growth for players in the surgical dressing market.
Foam dressing is an extremely absorbent dressing used for wound care. Foam dressings need less changing of dressings when compared to other types of dressings. Foam dressing works for heavily exuding wounds, like weeping ulcers, deep cavity wounds, wounds caused after debridement, etc.
Foam dressings are usually prescribed for their biggest advantage: providing a moist and warm environment, which is ideal for healing. These dressings are majorly used for full or partial-thickness wounds, that have moderate or more drainage. Furthermore, these dressings serve as a cushion to protect the affected area and also act as a barrier against bacteria during compression therapy. The ability of these dressings to be used as primary dressings or secondary dressings during accidents or other serious cases is expected to increase its adoption.
North America has dominated the global market and this may be attributed to increasing lifestyle disorders, increasing awareness about organ transplantation and rise in the range and number of ASC. The other major factors that are also driving the market for surgical dressing in the United States are rapidly growing aging population, a high number of diabetic population, and the developed healthcare system which adapts to the novel innovations.
Added to that, companies such as Cardinal Health, Coloplast A/S, Integra Lifesciences, etc. are having a large portfolio of surgical dressing and these companies hold a healthy share in the United States. Hence, owing to the above-mentioned factors, the market studied is expected to be dominated by the United States.
The market players are committed to developing innovative healing solutions for customers and patients across the care continuum, generating proven clinical outcomes. The companies are also showing continuous growth and are developing new and differentiated products and services, which address the evolving healthcare needs among patients, providers, and consumers.